As a Free StocksGuide user, you can view scores for all 7,031 stocks worldwide.
8 Analysts have issued a Greenwich LifeSciences Inc forecast:
8 Analysts have issued a Greenwich LifeSciences Inc forecast:
| Jun '25 | 
         
    +/-
   
  
    %
   
 | 
      ||
| Revenue | - - | 
         
    -
 
        
       | 
      |
| Gross Profit | - - | 
         
    -
 
        
       | 
      |
| EBITDA | -18 -18 | 
         
      
        
        72%
      
      
        
        72%
      
 
        
       | 
      |
| EBIT (Operating Income) EBIT | -18 -18 | 
         
      
        
        72%
      
      
        
        72%
      
 
        
       | 
      |
| Net Profit | -18 -18 | 
         
      
        
        76%
      
      
        
        76%
      
 
        
       | 
      |
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.
| Head office | United States | 
| CEO | Snehal Patel | 
| Employees | 6 | 
| Founded | 2006 | 
| Website | greenwichlifesciences.com | 
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


